These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10940280)

  • 21. Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.
    Masoodi M; Pearl DS; Eiden M; Shute JK; Brown JF; Calder PC; Trebble TM
    PLoS One; 2013; 8(10):e76532. PubMed ID: 24204637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
    Tozaki H; Odoriba T; Okada N; Fujita T; Terabe A; Suzuki T; Okabe S; Muranishi S; Yamamoto A
    J Control Release; 2002 Jul; 82(1):51-61. PubMed ID: 12106976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results.
    Pagnini C; Menasci F; Festa S; Rizzatti G; Corleto VD; Delle Fave MM; D'Ambra G; Di Giulio E; Delle Fave G
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3674-81. PubMed ID: 26502857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis.
    Ishiguro Y
    J Gastroenterol; 1999 Feb; 34(1):66-74. PubMed ID: 10204613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels.
    Abinusawa A; Tenjarla S
    Adv Ther; 2015 May; 32(5):477-84. PubMed ID: 25951927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesalazine vanishing time from rectal mucosa following its topical administration.
    Pimpo MT; Galletti B; Palumbo G; Viscido A; Gentile P; Caprilli R; Frieri G
    J Crohns Colitis; 2010 Feb; 4(1):102-5. PubMed ID: 21122491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Localization of salazopyrin in colonic mucosa patients with ulcerative colitis].
    Kitano A; Tabata A; Obayashi M; Nakagawa M; Yasuda K; Fukushima R; Okabe H; Tomobuchi M; Nakamura S; Kashima K
    Nihon Shokakibyo Gakkai Zasshi; 1993 Feb; 90(2):124-33. PubMed ID: 8096555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential utility of a new ulcerative colitis segmental endoscopic index combining disease severity and the extent of inflammation.
    Suzuki Y; Uchiyama K; Kato M; Matsuo K; Nakagawa T; Kishikawa H; Kimura N; Kasanuki J; Ino S
    J Clin Gastroenterol; 2015; 49(5):401-6. PubMed ID: 25127112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission.
    Rosenberg L; Nanda KS; Zenlea T; Gifford A; Lawlor GO; Falchuk KR; Wolf JL; Cheifetz AS; Goldsmith JD; Moss AC
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):991-6. PubMed ID: 23591275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confocal laser endomicroscopy: a new gold standard for the assessment of mucosal healing in ulcerative colitis.
    Macé V; Ahluwalia A; Coron E; Le Rhun M; Boureille A; Bossard C; Mosnier JF; Matysiak-Budnik T; Tarnawski AS
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():85-92. PubMed ID: 25827810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis.
    D'Incà R; Barollo M; Scarpa M; Grillo AR; Brun P; Vettorato MG; Castagliuolo I; Sturniolo GC
    Dig Dis Sci; 2011 Apr; 56(4):1178-87. PubMed ID: 20737210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis.
    Cuffari C; Pierce D; Korczowski B; Fyderek K; Van Heusen H; Hossack S; Wan H; Edwards AY; Martin P
    Drug Des Devel Ther; 2016; 10():593-607. PubMed ID: 26893546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
    Meckel K; Li YC; Lim J; Kocherginsky M; Weber C; Almoghrabi A; Chen X; Kaboff A; Sadiq F; Hanauer SB; Cohen RD; Kwon J; Rubin DT; Hanan I; Sakuraba A; Yen E; Bissonnette M; Pekow J
    Am J Clin Nutr; 2016 Jul; 104(1):113-20. PubMed ID: 27281309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standard treatment of ulcerative colitis.
    Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
    Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study.
    Nagahori M; Kochi S; Hanai H; Yamamoto T; Nakamura S; Omuro S; Watanabe M; Hibi T;
    BMC Gastroenterol; 2017 Apr; 17(1):47. PubMed ID: 28390410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic and histological patchiness in treated ulcerative colitis.
    Kim B; Barnett JL; Kleer CG; Appelman HD
    Am J Gastroenterol; 1999 Nov; 94(11):3258-62. PubMed ID: 10566726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.